Posts
February 26 2013
Celsion Corporation announced the closing of their Registered Direct offering in the amount of $15,000,004. EG&S acted as counsel to the Placement Agent.
February 22 2013
Provectus Pharmaceuticals, Inc. announced the closing of their PIPE offering in the amount of $2,550,000. EG&S acted as counsel to the Investor.
February 20 2013
Novelos Therapeutics, Inc. announced the closing of their PIPE offering in the amount of $5,500,000. EG&S acted as counsel to the Placement Agent.
February 15 2013
Atlas Financial Holdings, Inc. announced the closing of its initial public offering; 1,500,000 shares were sold by AFH and 2,625,000 shares were sold on behalf of selling shareholders. Total proceeds raised in the offering were $23,517,000. EG&S acted as counsel to Atlas.
February 15 2013
Nautilus Marine Acquisition Corp. (NASDAQ:NMAR) announced the completion of its acquisition of Assetplus Limited, a maritime energy services company controlling an initial fleet of vessels consisting of two platform supply vessels and two oil spill response vessels, as well as six binding time charter contracts with Brazilian oil major Petróleo Brasileiro S.A. In connection therewith, Nautilus completed its self-tender offer for up to 4,137,300 shares of its common stock at a price of $10.10 per share. EG&S acted as counsel to Nautilus.
February 14 2013
Desert Gateway, Inc. announced the closing of their PIPE offering in the amount of $10,000,000. EG&S acted as counsel to the Investor.
February 11 2013
Opexa Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $3,250,002. EG&S acted as counsel to the Placement Agent.
February 05 2013
ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $729,998. EG&S acted as counsel to the Placement Agent.